A5069132288- Treatment of Major Depression
- Psychedelics and Drug Studies
- Tryptophan and brain disorders
- Natural Compound Pharmacology Studies
- Anesthesia and Neurotoxicity Research
- Anesthesia and Sedative Agents
- Pharmacological Receptor Mechanisms and Effects
- Maternal Mental Health During Pregnancy and Postpartum
- Cannabis and Cannabinoid Research
- Mental Health and Patient Involvement
- Pain Management and Placebo Effect
- Medicinal Plant Extracts Effects
- Bipolar Disorder and Treatment
- Medicinal Plants and Bioactive Compounds
- Fluorine in Organic Chemistry
- Neurotransmitter Receptor Influence on Behavior
- Cross-Cultural and Social Analysis
- Functional Brain Connectivity Studies
- Chemical synthesis and alkaloids
Lesbian, Gay, Bisexual and Transgender Community Center
2023
University of Maryland, Baltimore
2014
San Francisco Center for Psychoanalysis
2014
Harvard University
2014
Johns Hopkins University
2014
Abstract The success of modern medicine creates a growing population those suffering from life-threatening illnesses (LTI) who often experience anxiety, depression, and existential distress. We present novel approach; investigating MDMA-assisted psychotherapy for the treatment anxiety in people with an LTI. Participants LTI were randomized double-blind study to receive MDMA (125 mg, n = 13) or placebo (n 5) combination two 8-h sessions. primary outcome was change State-Trait Anxiety...
Ketamine-assisted psychotherapy is a promising new treatment for variety of mental disorders adolescence. There currently an adolescent health crisis, with high prevalence disorders, diagnostic complexity, and many adolescents failing to respond conventional treatments. While there strong evidence the use ketamine in adults treatment-refractory illnesses, research its early stages. (KAP) has been described results here we present first published cases KAP adolescents. The four include aged...
1972 to 1976.He studied psychedelic psychotherapy with Stanislav Grof, M.D. and other
Ketamine is a general anesthetic with over 50 years of safe administration that in increasing use for psychiatric indications. This evidenced by the recent FDA approval intranasal esketamine (the S-enantiomer) treatment depression. With respect to ketamine and lactation, incredibly there are no available data on secretion or its metabolites human breast milk. information essential guide breastfeeding women who suffer postpartum emotional disorders, ongoing depression, PTSD, more. To address...
(1986). Meetings at the Edge with Adam: A Man for All Seasons? Journal of Psychoactive Drugs: Vol. 18, MDMA: Proceedings Conference, pp. 329-333.
A discussion of the nature transformation and its relationship to psychedelic experiencesparticularly ketamine experiences-is presented discussed along with a schema for thinking about types states that may be encountered transformations occur related use practice.This is followed by longitudinal historical approach portraying examining personal proposed instrument-The Transformational Codex-for cataloging history elements compose it.
Ethnographic Accounts of Ketamine Explorations in Psychedelic CultureOff-label use ketamine as a mind-altering substance did not begin the laboratory, but psychedelic culture that grew out 1960s counterculture movement.Whatever risks and limitations such experimentation, without them remarkable therapeutic effects drug might well have gone unnoticed, unresearched.The following personal accounts-both inspiring cautionary-offer glimpses into cultural contexts found to be much more than...
Abstract: There is no available data on the secretion and concentration of ketamine its metabolites in breastmilk. are statements literature made as to safety use lactating women, though these unsupported. This information pertinent for treatment breastfeeding women who may have depression, PTSD, postpartum other emotional difficulties would benefit from treatment. The objective this study was measure presence breastmilk three metabolites. We provided a longitudinal pharmacokinetic analysis...
Ketamine (IM) Assisted Psychotherapy Informed Consent FormWhat is Ketamine?K etamine now a validated "off-label" treatment for various chronic "treatment-resistant" mental illnesses.Ketamine Schedule III medication that has long been used safely as an anesthetic agent and now, at times, effectively depression, alcoholism, substance dependencies, PTSD other psychiatric diagnoses. How Does It Work?T he current, most probable, understanding of ketamine's mode action NMDA
Prior studies have reported variously on the presence or absence of dissociative effects at subanesthtetic doses ketamine administered for treatment-resistant depression.This mixedmethods study emulated protocol used in question, with IV administration 0.5mg/kg over 40 minutes eight experienced users.Quantitative measures were generally insignificant since this was not a population reporting depression; blood pressure increased as expected by 20-30mm systolic and 6-20mm diastolic, falling...